NAGPUR, India, Nov. 19, 2020 /PRNewswire/ — To fight the Novel coronavirus SARS-COV-2, the virus behind the worldwide outbreak of COVID-19 disease, a Nagpur based Indian biotechnology company, GeNext Genomics (GNG), is contributing by isolating the antibody gene pool of the cured[…]
Read MoreThe severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for an ongoing pandemic that has killed over 4,75,00 people globally and 14000 people alone in India. Also, the disease has paralyzed the global economy because of its devastating infection and widespread.[...]
Read More